High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
Primary Purpose
Urticaria
Status
Unknown status
Phase
Phase 3
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Vitamin D3 (High dose)
Vitamin D3 (Low dose)
Sponsored by
About this trial
This is an interventional treatment trial for Urticaria
Eligibility Criteria
Inclusion Criteria:
- Uriticaria or angioedema daily or more than 3 days a weeks for at least 6 weeks
Exclusion Criteria:
- Physical urticaria aquired or hereditary angioedema Calcium level > 10.3 mg/dl Glomerular filtration rate <50 Sarcoidosis Primary hyperparathyroidism Granulomatous diseases Malignancies Pregnancy Lactation
Sites / Locations
- Shiraz University of Medical SciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Vitamin D3 (Low dose)
Vitamin D3 (High dose)
Arm Description
Daily 600 unites of vitamin D + Cetirizine 10mg twice a day
Daily 4000 unites vitamin D + Cetirizine 10mg twice a day
Outcomes
Primary Outcome Measures
Urticaria symptom severity questionnaire after 1 week
Urticaria Symptom Severity ranging from 0 to 93
Secondary Outcome Measures
Urticaria symptom severity questionnaire after 6 week
Urticaria Symptom Severity ranging from 0 to 93
Urticaria symptom severity questionnaire after 12 week
Urticaria Symptom Severity ranging from 0 to 93
Full Information
NCT ID
NCT02873364
First Posted
August 11, 2016
Last Updated
August 16, 2016
Sponsor
Shiraz University of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT02873364
Brief Title
High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
Official Title
High Dose Vitamin D Supplementation in Treatment of Chronic Spontaneous Urticaria
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Unknown status
Study Start Date
August 2016 (undefined)
Primary Completion Date
December 2016 (Anticipated)
Study Completion Date
January 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shiraz University of Medical Sciences
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Chronic spontaneous urticaria is an inflammatory disease which is characterized with intermittent or daily urticaria. This diseases lasts for more than 6 weeks. Several recent studies have suggested a role for vitamin D in modulation of immune system and pathogenesis of chronic urticaria.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urticaria
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Vitamin D3 (Low dose)
Arm Type
Active Comparator
Arm Description
Daily 600 unites of vitamin D + Cetirizine 10mg twice a day
Arm Title
Vitamin D3 (High dose)
Arm Type
Experimental
Arm Description
Daily 4000 unites vitamin D + Cetirizine 10mg twice a day
Intervention Type
Drug
Intervention Name(s)
Vitamin D3 (High dose)
Other Intervention Name(s)
cholecalciferol
Intervention Description
Daily 4000 unites vitamin D
Intervention Type
Drug
Intervention Name(s)
Vitamin D3 (Low dose)
Other Intervention Name(s)
cholecalciferol
Intervention Description
Daily 600 unites vitamin D
Primary Outcome Measure Information:
Title
Urticaria symptom severity questionnaire after 1 week
Description
Urticaria Symptom Severity ranging from 0 to 93
Time Frame
1 weeks
Secondary Outcome Measure Information:
Title
Urticaria symptom severity questionnaire after 6 week
Description
Urticaria Symptom Severity ranging from 0 to 93
Time Frame
6 weeks
Title
Urticaria symptom severity questionnaire after 12 week
Description
Urticaria Symptom Severity ranging from 0 to 93
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Uriticaria or angioedema daily or more than 3 days a weeks for at least 6 weeks
Exclusion Criteria:
Physical urticaria aquired or hereditary angioedema Calcium level > 10.3 mg/dl Glomerular filtration rate <50 Sarcoidosis Primary hyperparathyroidism Granulomatous diseases Malignancies Pregnancy Lactation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Keramatallah Jahanshahi, MD
Phone
+989177416523
Email
kjahanshahi91@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Keramatallah Jahanshahi, MD
Organizational Affiliation
Shiraz University of Medical Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shiraz University of Medical Sciences
City
Shiraz
State/Province
Fars
Country
Iran, Islamic Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Keramatallah Jahanshahi, MD
Phone
+989177416523
Email
kjahanshahi91@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
We'll reach out to this number within 24 hrs